Cargando…

Assessment of Natriuretic Peptides: The Heart Should Be Evaluated as a Whole

Detalles Bibliográficos
Autores principales:	Yalcinkaya, Emre, Celik, Murat, Buyukturan, Galip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia 2014
Materias:	Letter To The Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987326/ https://www.ncbi.nlm.nih.gov/pubmed/24714797 http://dx.doi.org/10.5935/abc.20140027

Ejemplares similares

Evaluation of inflammatory conditions associated with aspirin resistance
por: Yalcinkaya, Emre, et al.
Publicado: (2014)

Assessment of Diastolic Dysfunction: Drugs Could Alter the Results
por: Yalcinkaya, Emre, et al.
Publicado: (2014)

Evaluation of right ventricle with echocardiography: Utility of combined techniques
por: Yalcinkaya, Emre, et al.
Publicado: (2013)

Extracellular Matrix Turnover: a Balance between MMPs and their Inhibitors
por: Yalcinkaya, Emre, et al.
Publicado: (2014)

Determining an optimal technique for atrial septal defect closure: percutaneous closure as a therapeutic modality of choice
por: Yalcinkaya, Emre, et al.
Publicado: (2014)

Cardiomyopathies: The Value of Cardiac Magnetic Resonance Imaging
por: Yalcinkaya, Emre, et al.
Publicado: (2014)

Caveats in the interpretation of natriuretic peptide levels
por: Chao, Chia-Ter
Publicado: (2011)

Can atrial natriuretic peptides measurement diagnose heart failure at different age groups?
por: Golabchi, Allahyar
Publicado: (2012)

Brain natriuretic peptide among stroke patients
por: Saritas, Ayhan, et al.
Publicado: (2014)

Awareness of atrial fibrogenesis and natriuretic peptide release
por: Meijers, W. C. F. W., et al.
Publicado: (2017)

B-type natriuretic peptide for the prediction of left ventricular remodelling
por: Bauters, Christophe, et al.
Publicado: (2014)

Natriuretic peptide and cardiac troponin levels in doxorubicin-induced cardiotoxicity
por: Gülgün, Mustafa, et al.
Publicado: (2016)

Brain Natriuretic Peptides in Screening of Syncope with Cardiac Origin; a Commentary
por: Feiz Disfani, Hamideh, et al.
Publicado: (2018)

Role of natriuretic peptide receptor C signalling in obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension
por: Eroume-A Egom, Emmanuel, et al.
Publicado: (2020)

A new algorithm of suspected stroke patient management with brain natriuretic peptide/N-terminal pro-brain natriuretic peptide point of care testing platform in the emergency department
por: He, Mingfeng, et al.
Publicado: (2017)

N-terminal pro brain natriuretic peptide in coronary artery disease
por: Tin, Sim Sai, et al.
Publicado: (2015)

Low voltage areas, atrial natriuretic peptides and fibrosis: Challenges and controversies
por: Floria, Mariana, et al.
Publicado: (2020)

Reply to: N-terminal pro brain natriuretic peptide in coronary artery disease
por: Radwan, Hanan, et al.
Publicado: (2015)

Authors’ reply: role of natriuretic peptide receptor C signalling in obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension
por: Agrawal, Vineet, et al.
Publicado: (2020)

Opinions about the use of brain natriuretic peptide among acute ischemic stroke patients
por: Wu, Zhixin, et al.
Publicado: (2013)

B-type natriuretic peptide may have a role in the management of patent ductus arteriosus
por: Lee, Jang Hoon
Publicado: (2018)

A Stranger in the Heart Part 2: Recurrence
por: Yalçınkaya Öner, Damla, et al.
Publicado: (2023)

Comments to “Neutrophil-to-lymphocyte ratio compared to N-terminal pro-brain natriuretic peptide as a prognostic marker of adverse events in elderly patients with chronic heart failure”
por: Cosansu, Kahraman, et al.
Publicado: (2017)

So‐far overlooked HFpEF patients with normal natriuretic peptide level need more evidence
por: Tanaka, Atsushi, et al.
Publicado: (2022)

Should the Sleepio programme be available free of charge across the whole of the UK?
por: Atenstaedt, Rob
Publicado: (2023)

Clinical Applications of Natriuretic Peptides in Assessment of Valvular Heart Disease
por: Sharma, Abhishek, et al.
Publicado: (2015)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

Epicardial Adipose Tissue Should Be Evaluated with Other Inflammatory Markers in Patients with Subclinical Hypothyroidism
por: Balta, Sevket, et al.
Publicado: (2013)

Combined Use of Serum N-terminal Pro-B-Type Natriuretic Peptide and Glypican-6 in the Diagnosis of Heart Failure
por: Sağlam, Emre Cem, et al.
Publicado: (2023)

Should We Leave Patients with an Only Hearing Ear to Their Fate?
por: Kalcioglu, M. Tayyar, et al.
Publicado: (2016)

ADMA is a useful marker, but many confounding factors should be considered!
por: Balta, Şevket, et al.
Publicado: (2015)

Should Publication be the Only Means of Assessment?
por: Patra, Bichitra Nanda, et al.
Publicado: (2013)

The Use of Brain Natriuretic Peptide in the Evaluation of Heart Failure in Geriatric Patients
por: Marinescu, Mihai, et al.
Publicado: (2023)

Natriuretic Peptides in Assessment of Ventricular Dysfunction
por: Gorenjak, Maksimiljan
Publicado: (2003)

Should We Be Afraid of Antiplatelet Treatment before Carotid Endarterectomy?
por: Sucu, Nehir, et al.
Publicado: (2018)

Should Publications be the Only Means of Assessment? Some Alternatives!
por: Gnanavel, Sundar
Publicado: (2014)

Cardiac congestion assessed by natriuretic peptides oversimplifies the definition and treatment of heart failure
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

In reply: efficacy of a new videolaryngoscope; what we should assess?
por: Asai, Takashi, et al.
Publicado: (2012)

C-type natriuretic peptide: the heart’s guardian angel
por: Sangaralingham, S Jeson, et al.
Publicado: (2020)

Role of Cardiac Natriuretic Peptides in Heart Structure and Function
por: Sarzani, Riccardo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a52ovl2i71gas1dgok8711qbbj